| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $154K | -0.3% |
| SG&A Expense | $748K | -67.7% |
| Operating Income | -$902K | +63.4% |
| Income Tax | $0 | — |
| Net Income | -$2.7M | +43.7% |
| EPS (Basic) | -$0.06 | +73.9% |
| EPS (Diluted) | -$0.06 | +73.9% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21K | -2.4% |
| Current Assets | $62K | -0.0% |
| Total Assets | $62K | -0.0% |
| Current Liabilities | $10.1M | +28.3% |
| Total Liabilities | $10.1M | +28.3% |
| Stockholders' Equity | -$10.0M | -28.5% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$215K | +65.5% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $215K | -63.1% |